Tuberculosis Among Native Hawaiian and Other Pacific Islander Persons: United States and U.S.-Affiliated Pacific Islands, 2010-2019.

U.S.-Affiliated Pacific Islands tuberculosis

Journal

Health equity
ISSN: 2473-1242
Titre abrégé: Health Equity
Pays: United States
ID NLM: 101708316

Informations de publication

Date de publication:
2022
Historique:
accepted: 14 05 2022
entrez: 8 7 2022
pubmed: 9 7 2022
medline: 9 7 2022
Statut: epublish

Résumé

In recent years, tuberculosis (TB) incidence in the United States has declined overall but remained high among Native Hawaiian and Other Pacific Islander (NH/PI) persons. Few studies have examined the epidemiology of TB among NH/PI persons, particularly in the U.S.-Affiliated Pacific Islands (USAPI). We describe TB incidence and characteristics of NH/PI patients during 2010-2019. We used data from the National Tuberculosis Surveillance System to characterize TB cases reported among NH/PI persons born in the 50 U.S. states (defined to include District of Columbia) and the USAPI. We calculated annual TB incidence among NH/PI patients, stratified by place of birth (U.S. states or USAPI). Using Asian persons born outside the United States-persons historically grouped with NH/PI persons as one racial category-as the reference, we compared demographic, clinical, and socio-behavioral characteristics of NH/PI TB patients. During 2010-2019, 4359 TB cases were reported among NH/PI patients born in the U.S. states ( TB incidence among NH/PI persons is high, particularly among persons born in the USAPI, emphasizing the need to enhance TB prevention strategies in these communities. Interventions should be tailored toward those who experience the highest risk, including NH/PI children and adolescents.

Sections du résumé

Background UNASSIGNED
In recent years, tuberculosis (TB) incidence in the United States has declined overall but remained high among Native Hawaiian and Other Pacific Islander (NH/PI) persons. Few studies have examined the epidemiology of TB among NH/PI persons, particularly in the U.S.-Affiliated Pacific Islands (USAPI). We describe TB incidence and characteristics of NH/PI patients during 2010-2019.
Methods UNASSIGNED
We used data from the National Tuberculosis Surveillance System to characterize TB cases reported among NH/PI persons born in the 50 U.S. states (defined to include District of Columbia) and the USAPI. We calculated annual TB incidence among NH/PI patients, stratified by place of birth (U.S. states or USAPI). Using Asian persons born outside the United States-persons historically grouped with NH/PI persons as one racial category-as the reference, we compared demographic, clinical, and socio-behavioral characteristics of NH/PI TB patients.
Results UNASSIGNED
During 2010-2019, 4359 TB cases were reported among NH/PI patients born in the U.S. states (
Conclusions UNASSIGNED
TB incidence among NH/PI persons is high, particularly among persons born in the USAPI, emphasizing the need to enhance TB prevention strategies in these communities. Interventions should be tailored toward those who experience the highest risk, including NH/PI children and adolescents.

Identifiants

DOI: 10.1089/heq.2022.0065 PMID: 35801148 PMC: PMC9257550
pubmed: 35801148
doi: 10.1089/heq.2022.0065
pii: 10.1089/heq.2022.0065
pmc: PMC9257550
doi:

Types de publication

Journal Article

Langues

eng

Pagination

476-484

Informations de copyright

© Molly Deutsch-Feldman et al., 2022; Published by Mary Ann Liebert, Inc.

Déclaration de conflit d'intérêts

No competing financial interests exist.

Références

Hawaii J Med Public Health. 2017 May;76(5):133-134
pubmed: 28484668
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1267-1273
pubmed: 34529634
Int J Tuberc Lung Dis. 2015 Jan;19(1):111-9
pubmed: 25519800
Public Health Rep. 2011 Sep-Oct;126(5):677-89
pubmed: 21886328
Clin Infect Dis. 2017 Jan 15;64(2):111-115
pubmed: 28052967
BMJ Open Diabetes Res Care. 2020 Jul;8(1):
pubmed: 32641300
J Racial Ethn Health Disparities. 2021 Aug 26;:
pubmed: 34448124
Emerg Infect Dis. 2011 Jul;17(7):1202-8
pubmed: 21762573
Am J Public Health. 2005 May;95(5):873-80
pubmed: 15855468
Asia Pac J Public Health. 2022 Mar;34(2-3):258-261
pubmed: 34872367
Clin Infect Dis. 2009 Jan 1;48(1):72-82
pubmed: 19046064
Vital Health Stat 3. 2017 Jul;(40):1-99
pubmed: 30248010
NCHS Data Brief. 2017 Mar;(277):1-8
pubmed: 28437238
Drugs. 2011 Jun 18;71(9):1133-52
pubmed: 21711060
Pediatr Clin North Am. 2017 Aug;64(4):893-909
pubmed: 28734517
Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:9-16
pubmed: 26564535

Auteurs

Molly Deutsch-Feldman (M)

Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STDs, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
ORCID: 0000-0001-6191-930X

Yuri P Springer (YP)

Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STDs, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Derrick Felix (D)

Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STDs, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Clarisse A Tsang (CA)

Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STDs, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Richard Brostrom (R)

Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STDs, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Maryam Haddad (M)

Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STDs, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Classifications MeSH